Advertisement
Indian
Tata in talks to launch Moderna COVID-19 vaccine in India
Tata Medical & Diagnostics could team up with the India’s Council of Scientific and Industrial Research to carry out clinical trials of Moderna’s vaccine candidate in India,
Data released in November from Moderna’s late-stage study showed it was 94.1% effective with no serious safety concerns. The shot was approved for use in the United States in December and in Europe earlier this month.
Cairn Energy threatens to enforce arbitration award against Indian assets overseas
Cairn was awarded damages of over $1.2 billion plus interest and costs in a long drawn-out tussle over a tax dispute and the Indian government is now liable to make this payment. An Indian official, however, said at the time the government would likely challenge the order.
If India does not comply with the order it would be a violation of international rules on arbitral awards, commonly called the New York Convention, Cairn said in a letter addressed to the Indian High Commission in London.
IRDAI unveils `Standard Individual Immediate Annuity Product”, to be mandatorily offered by life insurers from Apr 1
The entry age for a customer to buy an annuity product is 40 years and maximum age is 80 years.The minium annuity amount under the proposed policy will be Rs. 1000 per month, Rs. 3000 per quarter, Rs. 6000 per half year and Rs. 12000 per annum.
Though pricing is left to the insurers, annuity rates should be derived based on actuarial principles and ensure that such annuity rates are fair and reasonable to customers.
Soon customers, needing pension products, could get an opportunity to buy guaranteed return products from the National Pension System (NPS) for building their retirement corpus. So far, the NPS has remained a market-linked pension scheme.
Delhi could be heading towards attaining ‘herd immunity’, indicates latest sero-survey
Herd immunity implies that in any set of people in a community, after becoming affected by the virus, a lot many of them become immune to it, on account of antibodies developed in response to it. And, hence, such people become a protective layer between the infected person and unaffected people, thereby breaking the chain of viral transmission.
International
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Briefs
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Events
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Advertisement
Articles
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Features
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Data
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Interviews
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Facts
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
